GRAY SUSANNAH

CIK 00018334535 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001833453

Recent Transactions

34 trades

Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2025-06-17+22,500→ 22,500 total
Award
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2025-06-16$2.16/sh+89,139→ 169,907 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2025-05-19+10,649→ 42,137 total
Disposition to Issuer
Morphic Holding, Inc.
Stock Option (Right to Buy)
2024-08-16−12,535→ 0 total
Disposition to Issuer
Morphic Holding, Inc.
Stock Option (Right to Buy)
2024-08-16−18,111→ 0 total
Disposition to Issuer
Morphic Holding, Inc.
Stock Option (Right to Buy)
2024-08-16−23,168→ 0 total
Disposition to Issuer
Morphic Holding, Inc.
Stock Option (Right to Buy)
2024-08-16−17,550→ 0 total
Award
Morphic Holding, Inc.
Common Stock
2024-06-04+23,168→ 23,168 total
Award
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2024-05-23$10.78/sh+20,645→ 80,768 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-05-21+22,500→ 22,500 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2024-05-08+10,537→ 31,488 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 total
Award
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2023-07-17+24,000→ 60,123 total
Award
Morphic Holding, Inc.
Director Stock Option (Right to Buy)
2023-06-01+12,535→ 12,535 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-05-23+22,500→ 22,500 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-05-02+9,132→ 20,951 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-05-02+22,044→ 22,044 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-02-26+28,000→ 28,000 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-02-26+4,666→ 4,666 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-02-26+10,131→ 10,131 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-02-26+1,688→ 11,819 total
Award
Morphic Holding, Inc.
Director Stock Option (Right to Buy)
2022-06-08+17,550→ 17,550 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-05-23+22,500→ 22,500 total
Disposition to Issuer
Apria, Inc.
Restricted Stock Units
2022-03-29$37.50/sh−5,059→ 0 total
Award
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2021-11-19+4,271→ 36,123 total
Award
Morphic Holding, Inc.
Director Stock Option (right to buy)
2021-06-16+12,000→ 12,000 total
Award
Morphic Holding, Inc.
Director Stock Option (right to buy)
2021-06-16+0→ 0 total
Award
Apria, Inc.
Restricted Stock Units
2021-06-10+5,059→ 5,059 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-05-17+22,500→ 22,500 total
Award
Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
2021-04-27+24,000→ 24,000 total
Award
Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
2021-04-27+18,111→ 18,111 total
Purchase
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2020-11-24$27.00/sh+20,000→ 31,852 total
Award
MARAVAI LIFESCIENCES HOLDINGS, INC.$MRVI
Class A Common Stock
2020-11-19+11,852→ 11,852 total

Companies

Recent Filings

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov